Optimizing methotrexate withdrawal during COVID vaccination

Results from two parallel trials suggest that withholding methotrexate only after the second dose of a COVID vaccine is safe and effective in patients with rheumatoid arthritis or psoriatic arthritis.

Detalles Bibliográficos
Autor principal: McHugh, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Research Highlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524381/
https://www.ncbi.nlm.nih.gov/pubmed/36180548
http://dx.doi.org/10.1038/s41584-022-00856-7
_version_ 1784800495850749952
author McHugh, Jessica
author_facet McHugh, Jessica
author_sort McHugh, Jessica
collection PubMed
description Results from two parallel trials suggest that withholding methotrexate only after the second dose of a COVID vaccine is safe and effective in patients with rheumatoid arthritis or psoriatic arthritis.
format Online
Article
Text
id pubmed-9524381
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95243812022-10-03 Optimizing methotrexate withdrawal during COVID vaccination McHugh, Jessica Nat Rev Rheumatol Research Highlight Results from two parallel trials suggest that withholding methotrexate only after the second dose of a COVID vaccine is safe and effective in patients with rheumatoid arthritis or psoriatic arthritis. Nature Publishing Group UK 2022-09-30 2022 /pmc/articles/PMC9524381/ /pubmed/36180548 http://dx.doi.org/10.1038/s41584-022-00856-7 Text en © Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Research Highlight
McHugh, Jessica
Optimizing methotrexate withdrawal during COVID vaccination
title Optimizing methotrexate withdrawal during COVID vaccination
title_full Optimizing methotrexate withdrawal during COVID vaccination
title_fullStr Optimizing methotrexate withdrawal during COVID vaccination
title_full_unstemmed Optimizing methotrexate withdrawal during COVID vaccination
title_short Optimizing methotrexate withdrawal during COVID vaccination
title_sort optimizing methotrexate withdrawal during covid vaccination
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524381/
https://www.ncbi.nlm.nih.gov/pubmed/36180548
http://dx.doi.org/10.1038/s41584-022-00856-7
work_keys_str_mv AT mchughjessica optimizingmethotrexatewithdrawalduringcovidvaccination

Ejemplares similares